The Masking Game: Design of Activatable Antibodies and Mimetics for Selective Therapeutics and Cell Control
Author
Lucchi, Roberta
Bentanachs, Jordi
Oller Salvia, Benjamí
Other authors
Universitat Ramon Llull. IQS
Publication date
2021-04-26ISSN
2374-7951
Abstract
The high selectivity and affinity of antibody binding havemade antibodies all-pervasive tools in therapy, diagnosis, and basic science.A plethora of chemogenetic approaches has been devised to makeantibodies responsive to stimuli ranging from light to enzymatic activity,temperature, pH, ions, and effector molecules. Within a single decade, thefield of activatable antibodies has yielded marketed therapeutics capable ofengaging antigens that could not be targeted with traditional antibodies, aswell as new tools to control intracellular protein location and investigatebiological processes. Many opportunities remain untapped, waiting formore efficient and generally applicable masking strategies to be developedat the interface between chemistry and biotechnology
Document Type
Article
Document version
Published version
Language
English
Subject (CDU)
616 - Pathology. Clinical medicine
Keywords
Antigens
Biopolymers
Cancer therapy
Immunology
Peptides and proteins
Antígens
Biopolímers
Càncer--Tractament
Immunologia
Pèptids
Proteïnes
Pages
15 p.
Publisher
American Chemical Society
Is part of
ACS Central Science
Grant agreement number
info:eu-repo/grantAgreement/EC/Grant No.844441
info:eu-repo/grantAgreement/MCIU/FPU19/03216
info:eu-repo/grantAgreement/SUR del DEC/SGR/SGR 2017 1559
This item appears in the following Collection(s)
Rights
© L'autor/a
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc/4.0/